Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001193125-25-266928
Filing Date
2025-11-05
Accepted
2025-11-05 16:10:00
Documents
13
Period of Report
2025-12-19

Document Format Files

Seq Description Document Type Size
1 PRE 14A acet-20251105.htm   iXBRL PRE 14A 323336
2 GRAPHIC img106677922_0.jpg GRAPHIC 11570
3 GRAPHIC img106677922_1.jpg GRAPHIC 195159
4 GRAPHIC img106677922_2.jpg GRAPHIC 235803
  Complete submission text file 0001193125-25-266928.txt   1681235

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT acet-20251105.xsd EX-101.SCH 40863
15 EXTRACTED XBRL INSTANCE DOCUMENT acet-20251105_htm.xml XML 1293
Mailing Address 131 DARTMOUTH STREET 3RD FLOOR BOSTON MA 02116
Business Address 131 DARTMOUTH STREET 3RD FLOOR BOSTON MA 02116 617-482-2333
Adicet Bio, Inc. (Filer) CIK: 0001720580 (see all company filings)

EIN.: 813305277 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-38359 | Film No.: 251454031
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)